News & Press Releases

11 May, 2023

A woman prepares for mammography exam, and receives direction from the clinician.

RadNet Responds to New USPSTF Breast Screening Recommendations

The U.S. Preventive Services Task Force (USPSTF), an important advisor on preventive health services, reversed a key breast cancer screening guideline yesterday. In a draft statement, the group now recommends that women get mammograms every two years starting at age 40, not age 50, as it stated...

9 May, 2023

RadNet Reports First Quarter Financial Results with Record First Quarter Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2023 Financial Guidance Ranges for Revenue and Adjusted EBITDA(1)

LOS ANGELES, May 09, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 363 owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2023.

4 May, 2023

Maryland Governor Moore Signs RadNet-supported Legislation to Make Follow-up Diagnostic Imaging for Breast and Lung Cancers More Affordable

ANNAPOLIS, Md., May 04, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), today announced that Maryland Governor Wes Moore signed into law legislation to improve lung and breast cancer detection and diagnosis in Maryland. House Bill (HB) 815/Senate Bill (SB) 965 and HB 376/SB 184 require state-regulated insurers to waive patient cost-shares for supplemental diagnostic imaging associated with lung and breast cancers, respectively. The bills were championed by RadNet and received unanimous support from the Maryland House and Senate.

3 May, 2023

Good Day Philadelphia Spotlights RadNet’s Use of AI for Early Breast Cancer Detection in Delaware

On Good Day Philadelphia, Dr. Jacqueline Holt, Medical Director of RadNet’s Delaware Imaging Network (DIN), discussed how artificial technology software works to assist radiologists in detecting breast cancer earlier. DIN leverages Saige-Dx™, an FDA-cleared AI technology developed by...

1 May, 2023

RadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 Software

LOS ANGELES, May 01, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for the third-generation release of its Quantib Prostate™ 3.0 MRI artificial intelligence (AI) software, further enhancing the offering with new and updated tools. Quantib Prostate™ software for MRI reading support was first introduced in the US, followed by a class IIb CE marking in Europe in 2021.

27 April, 2023

RadNet, Inc. Announces Date of its First Quarter 2023 Financial Results Conference Call

LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2023 financial results on Tuesday, May 9, 2023 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

12 April, 2023

BronxNet Community Television interviews Dr. Jacqueline Holt on RadNet's Enhanced Breast Cancer Detection Program

Dr. Jacqui Holt, one of our leading Medical Directors in Women's Imaging, sat down with BronxNet Community Television to talk about our Enhanced Breast Cancer Detection (EBCD) program. The interview highlights the importance of early detection, and how our FDA-cleared AI product helps our...

21 March, 2023

RadNet, Inc. to Present at the Sidoti & Company 2023 Virtual Spring Investor Conference on Wednesday, March 22nd

LOS ANGELES, March 21, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company Spring 2023 Conference on Wednesday, March 22nd at 01:00 p.m. Eastern Time.

13 March, 2023

RadNet, Inc. to Present at the Barclays Global Healthcare Conference on Thursday, March 16th

LOS ANGELES, March 13, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Barclays Global Healthcare Conference on Thursday, March 16, 2023 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time).

6 March, 2023

RadNet, Inc. to Present at the 43rd Annual Cowen & Company Healthcare Conference on Tuesday, March 7th

LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer and Gregory Sorensen, M.D., CEO and co-founder of DeepHealth (RadNet’s Artificial Intelligence Division), will be presenting at the Cowen & Company Healthcare Conference on Tuesday, March 7, 2023 at 9:50 a.m. Eastern Time (6:50 a.m. Pacific Time).

Welcome to the RadNet Newsroom

Follow Us

EXPLORE

CONNECT WITH US